Loading...
Ons wil graag hê dat jy deel word van ons gemeenskap. Sluit aan by ons Discord om met ons en ander lede te skakel!
- Ticker
- AMBU-B.CO
- Price
- 106.30
- Stock movement up
- +0.40 (0.38%)
- Company name
- Ambu A/S
- Exchange
- (CO ,
- Currency
- DKK )
- Sector
- Healthcare >Medical Devices
- Markkapitalisasie
- 24.67B
- Ondernemingswaarde
- 25.61B
- Prys/Verkope
- 4.58
- Prys/Boek
- 4.41
- Dividendopbrengs
- -
- Dividendgroei
- -
- Groei jare
- -
- FCF uitbetaling
- -
- Agterlopende P/E
- 104.97
- Volgende P/E
- 43.39
- PEG
- -
- EPS groei
- -7.23%
- 1 jaar opbrengs
- 2.41%
- 3 jaar opbrengs
- -12.99%
- 5 jaar opbrengs
- -0.66%
- 10 jaar opbrengs
- 17.68%
Laaste opgedateer: 2024-12-21
DIVIDENDE
AMBU-B.CO betaal nie dividende nie of geen data is ontvang nie
WAARDERING
Waarderingsverhoudings
Loading...
Waarderingsverhoudings gegewens
| Agterlopende P/E | 104.97 |
| Prys tot OCF | 30.34 |
| Prys tot FCF | 42.24 |
| Prys tot EBITDA | 47.62 |
| EV tot EBITDA | 49.45 |
Waardering (Verkope/Boekwaarde)
Loading...
Waardering (Verkope/Boekwaarde) gegewens
| Prys tot verkope | 4.58 |
| Prys tot Boekwaarde | 4.41 |
| EV tot verkope | 4.75 |
FINANSIËLE
Per aandeel
Loading...
Per aandeel gegewens
| Huidige aandeeltelling | 232.07M |
| EPS (TTM) | 0.89 |
| FCF per aandeel (TTM) | 2.21 |
Inkomstestaat
Loading...
Inkomstestaat gegewens
| Inkomste (TTM) | 5.39B |
| Bruto wins (TTM) | 3.20B |
| Bedryfsinkomste (TTM) | 311.00M |
| Netto inkomste (TTM) | 235.00M |
| EPS (TTM) | 0.89 |
| EPS (1j vorentoe) | 2.45 |
Marges
Loading...
Marges gegewens
| Bruto marge (TTM) | 59.38% |
| Bedryfsmarge (TTM) | 5.77% |
| Winsgrens (TTM) | 4.36% |
Balansstaat
Loading...
Skep asseblief 'n gratis rekening of meld aan om toegang tot hierdie grafiek te kry
Balansstaat gegewens
| Kontant | 615.00M |
| Netto debiteure | 829.00M |
| Totale bedryfsbates | 2.64B |
| Klandisiewaarde | 1.53B |
| Ontasbare bates | 1.70B |
| Eiendom, aanleg en toerusting | 0.00 |
| Totale bates | 7.15B |
| Rekeninge betaalbaar | 490.00M |
| Kort/huidige langtermynskuld | 558.00M |
| Totale bedryfslaste | 1.06B |
| Totale laste | 1.56B |
| Aandeelhouersbelang | 5.59B |
| Netto tasbare bates | 0.00 |
Kontantvloei
Loading...
Skep asseblief 'n gratis rekening of meld aan om toegang tot hierdie grafiek te kry
Kontantvloei gegewens
| Bedryfskontantvloei (TTM) | 813.00M |
| Kapitale uitgawes (TTM) | 229.00M |
| Vrye kontantvloei (TTM) | 584.00M |
| Dividende betaal (TTM) | 0.00 |
Finansiële opbrengste
Loading...
Skep asseblief 'n gratis rekening of meld aan om toegang tot hierdie grafiek te kry
Finansiële opbrengste gegewens
| Opbrengs op ekwiteit | 4.20% |
| Opbrengs op bates | 3.28% |
| Opbrengs op belegde kapitaal | 4.15% |
| Kontant opbrengs op belegde kapitaal | 10.30% |
AANDELE INLIGTING
Aandele grafiek
Loading...
Aandele prys data
| Open | 105.50 |
| Daaglikse hoog | 106.55 |
| Daaglikse laag | 103.85 |
| Daaglikse volume | 517K |
| Hoogtepunt van alle tye | 355.40 |
| 1j analiseraaming | 127.63 |
| Beta | 0.79 |
| EPS (TTM) | 0.89 |
| Dividend per aandeel | - |
| Ex-dividend datum | 5 Dec 2024 |
| Volgende verdienste datum | 30 Jan 2025 |
Afwaartse potensiaal
Loading...
Afwaartse potensiaal gegewens
| AMBU-B.CO | S&P500 | |
| Huidige prysdaling vanaf die hoogste punt van alle tye | -70.09% | -2.74% |
| Hoogste prysdaling | -82.62% | -56.47% |
| Datum van hoogste daling | 22 Sep 2022 | 9 Mar 2009 |
| Gemiddelde daling vanaf hoogtepunt | -31.82% | -11.13% |
| Gemiddelde tyd tot nuwe hoogtepunt | 24 days | 12 days |
| Maksimum tyd tot nuwe hoogtepunt | 1367 days | 1805 days |
MAATSKAPPY BESONDERHEDE
Markkapitalisasie
24.67B
Markkapitalisasie kategorie
Large-cap
Beskrywing
Ambu A/S, a medical technology company, develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, and displaying units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products; airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, resuscitators, video laryngoscopes, and training manikins. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.
Werknemers
5196
Webwerf
Beleggerverhoudings
-
SEC lêers
CEO
Land
Denmark
Stad
Aandele tipe
-
CCC status
-
Dividendfrekwensie
-
GEBEURE EN AANBIEDINGS
GebeureAanbiedings
Loading...
VERSTAAN DIE BESIGHEID
Loading...
MAATSKAPPY NUUS
Alle nuusPersvrystellings
In the wake of recent U.S. election results and a subsequent rally in major stock indices, global markets are witnessing heightened investor optimism fueled by expectations of economic growth and regu...
14 November 2024
As global markets continue to navigate a complex economic landscape, U.S. stocks have reached new highs, buoyed by a promising start to the earnings season despite some inflationary pressures and mixe...
16 Oktober 2024
Amid recent market turbulence, with the S&P 500 Index experiencing its steepest weekly drop in 18 months due to economic slowdown concerns, investors are seeking stability and growth. In this environm...
12 September 2024
As global markets continue to navigate volatility driven by economic growth concerns and technical factors, investors are increasingly seeking stability and potential upside in their portfolios. One s...
13 Augustus 2024
As global markets show signs of resilience, with indices like the Russell 2000 Index witnessing notable gains amidst fluctuating economic indicators, investors are keenly watching for opportunities th...
15 Julie 2024
As global markets navigate through a landscape of mixed economic signals and fluctuating indices, investors are closely monitoring trends that could influence their portfolios. Amidst this backdrop, g...
13 Junie 2024
As global markets show signs of resilience with indices like the S&P 500 nearing record highs and the UK economy emerging from recession, investors are closely monitoring shifts in market dynamics and...
15 Mei 2024
Pursuant to Ambu A/S’ (Ambu) Remuneration Policy, a total of 172,956 Performance Share Units (PSUs) related to Ambu’s long-term incentive programme (LTIP) for 2023/24 have been granted on 6 February 2...
6 Februarie 2024
In Q1 2023/24, Ambu delivered 14% organic revenue growth and a 10.0% EBIT margin before special items. This was driven by Endoscopy Solutions growing 25%, due to continued high double-digit growth wit...
30 Januarie 2024